Checkpoint blockade‐based immunotherapy in the context of tumor microenvironment: opportunities and challenges

J Duan, Y Wang, S Jiao - Cancer medicine, 2018 - Wiley Online Library
A dynamic and mutualistic interaction between tumor cells and tumor microenvironment (
TME ) promotes the progression and metastasis of solid tumors. Cancer immunotherapy is …

Neratinib, an irreversible ErbB receptor tyrosine kinase inhibitor, in patients with advanced ErbB2-positive breast cancer

…, R Paridaens, AR Tan, A Awada, A Ranade, S Jiao… - J Clin Oncol, 2010 - ejcancer.com
Purpose Neratinib is an oral, irreversible pan-ErbB receptor tyrosine kinase inhibitor. The
efficacy and safety of neratinib were evaluated in two cohorts of patients with advanced ErbB2-…

Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial

…, Z Wei, F Tan, Y Wang, L Ding, H Dai, S Jiao… - The lancet …, 2013 - thelancet.com
Background Icotinib, an oral EGFR tyrosine kinase inhibitor, had shown antitumour activity
and favourable toxicity in early-phase clinical trials. We aimed to investigate whether icotinib …

Comprehensive characterization of cancer subtype associated long non-coding RNAs and their clinical implications

W Zhao, J Luo, S Jiao - Scientific reports, 2014 - nature.com
Long non-coding RNAs (lncRNAs) are a kind of RNAs with regulation that participate
fundamental cellular processes via diverse mechanisms. Despite the potential importance of …

Endobronchial ultrasound‐guided transbronchial needle biopsy for the diagnosis of intrathoracic lymph node metastases from extrathoracic malignancies: a meta …

…, F Li, W Shi, H Liu, S Sun, G Zhang, S Jiao - Respirology, 2014 - Wiley Online Library
Intrathoracic lymph node metastases in patients with extrathoracic malignancies are a common
clinical manifestation. Several studies evaluating intrathoracic lymph node metastases in …

[HTML][HTML] MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3

…, L Kang, B Han, J Meng, Z Yan, X Yan, S Jiao - Oncotarget, 2015 - ncbi.nlm.nih.gov
MiR-125a has been characterized as a tumor suppressor in several cancers. However, the
role of miR-125a in cervical cancer is unknown. In this study, we found the expression of miR-…

Pretreatment lactate dehydrogenase may predict outcome of advanced non small‐cell lung cancer patients treated with immune checkpoint inhibitors: A meta …

…, Y Li, X Yan, Q Song, G Wang, Y Hu, S Jiao… - Cancer …, 2019 - Wiley Online Library
The main aim of this study is to investigate whether baseline lactate dehydrogenase (LDH)
is associated with the clinical outcome of non small‐cell lung cancer (NSCLC) patients …

Efficacy and safety of bevacizumab for the treatment of advanced hepatocellular carcinoma: a systematic review of phase II trials

P Fang, J Hu, Z Cheng, Z Liu, J Wang, S Jiao - PloS one, 2012 - journals.plos.org
Background Hepatocellular carcinoma (HCC) is a common cancer associated with a poor
prognosis. Bevacizumab is a monoclonal antibody that binds vascular endothelial growth …

[HTML][HTML] Pretreatment neutrophil-to-lymphocyte ratio (NLR) may predict the outcomes of advanced non-small-cell lung cancer (NSCLC) patients treated with immune …

…, Y Hu, X Yan, Q Song, G Wang, R Chen, S Jiao… - Frontiers in …, 2020 - frontiersin.org
Background: Recent studies have demonstrated the predictive value of pretreatment
neutrophil-to-lymphocyte ratio (NLR) in advanced cancers; however, the role of NLR in patients with …

Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for …

J Wang, R Xu, J Li, Y Bai, T Liu, S Jiao, G Dai, J Xu… - Gastric cancer, 2016 - Springer
Background The V325 study showed that docetaxel, cisplatin, and fluorouracil (DCF) prolonged
overall survival (OS) of patients with advanced gastric cancer, but with a high incidence …